Stage 4 Breast Cancer Treatment

Precision Second Opinions Providing Alternative Breast Cancer Options


At Envita Medical Centers in Scottsdale, Arizona, we go beyond standardized treatment protocols by offering precision second opinions to establish genetically customized and personally targeted treatments including immunotherapy, chemotherapy, and natural therapy options.

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

Our methods are a unique approach to breast cancer treatment that utilize the most advanced genetic and environmental testing to build next-level personalized breast cancer treatment plans. We establish a true medical blueprint for you and use it to integrate a treatment plan uniquely suited to give you the best chance to improve your outcome.

Envita’s Precision Second Opinions and Becoming a Patient

The precision second opinion is a three-step process used to identify if Envita is the right option for you.

step 01
Oncology Care Navigation
Envita's Oncology Care Network team members work directly with you and our team of physicians to gather information and decide if Envita could be the right option for you.
step 02
Medical Record Collection
We gather all pertinent medical records to perform an in-depth analysis of previous care to learn specifics of your condition and identify potential treatment options that were missed.
step 03
Confirm Treatment Candidacy
Our team of physicians will confirm if they feel treatment would be appropriate for your case. Your Oncology Care Navigation team will discuss with you about the next steps towards receiving precision care at Envita.

Once your precision second opinion is completed our team of physicians will have a snapshot of your health and medical history and can begin to personalize treatment options that could be beneficial for your disease presentation. Your Oncology Care Navigation team member will work with you to begin the process of becoming a patient at Envita Medical Centers.

Envita Medical Centers’ Approach to Breast Cancer

Envita Medical Centers focuses on the treatment of persistent and late-stage breast cancer and has been doing so for over two decades.

All too often patients are not diagnosed early enough, and the possible spread of their cancer is not screened for, resulting in recurrence of disease after first pursuing conventional oncology care.

Fortunately, this is where Envita puts its focus, on undoing the damage not properly targeted standardized treatment protocols can have on the body while helping our patients achieve a better response to care using the latest innovations in breast cancer treatment options.

Most of the patients who find their way to Envita have experienced an approach to care that was focused on managing the disease as opposed to treating the source.

We have been successful at helping our patients respond more favorably to treatment after they have exhausted all standardized medical options because we break away from the “cookie-cutter” approach to care and truly look at the patient as an individual and not just a diagnosis.

Standardized Breast Cancer Treatment Limitations

Most standardized breast cancer treatment is based around the National Comprehensive Cancer Network’s (NCCN) guidelines.

NCCN’s guidelines are one-size-fit-all protocols that use the same old combination of surgery, radiation, chemotherapy, and hormone blockers followed by clinical trials and finally hospice if the patient does not respond.

This method of treatment is taxing and invasive with the potential for debilitating side-effects while yielding unreliable results.

Treatment Selection Based on Your Needs

Doctor and patient

Because of our truly integrative approach, we are not bound to the protocols approved by the NCCN and can use the latest treatment options from around the world to help attack your breast cancer.

At Envita we use cutting-edge, proprietary oncology using genetically targeted chemotherapies that can precisely attack your breast cancer while reducing the potential side-effects on your body.

Instead of using massive clinical trials based on cancer type and stage to determine what chemotherapy to use, we gather real-time biomarker information from your circulating tumor cells and test them to identify which chemotherapies and natural adjunctive agents will work best against your unique cancer.

We excel at recognizing circulating tumor cells and free-floating DNA, giving us the upper hand at identifying and treating metastasized breast cancer. Using our expertise, we go beyond NCCN guidelines to provide truly personalized medicine tailored to your specific needs.

We combine this with a multitude of integrative treatments from around the world to build a multifaceted treatment protocol targeted towards fighting your breast cancer and the root causes of your condition.

We attack your cancer from all angles, utilizing a personalized combination of immunotherapies, detoxification methods, patient specific chemotherapies, and genetic therapies created and combined in Envita’s own in-house pharmacy to ensure the treatments delivered to you are of the highest quality and potency.

Envita’s In-House Pharmacy, Vertisis Custom Pharmacy

Vertisis Custom Pharmacy

Envita would not be able to provide the comprehensive in-depth care it has established without the help of Vertisis Custom Pharmacy, our in-house custom pharmacy.

All the medications including natural medicines, chemotherapies, and immunotherapies are custom prepared in our pharmacy and are built specifically for our patients’ genetic needs.

Other clinics may use genetic targeting for their treatment, but they are limited to what medications are commercially available.

At Vertisis, our team customizes medications based on your specific needs making Envita a truly unique and cutting-edge cancer clinic.

During our 20 years of treating cancer and chronic disease, Envita Medical Centers has been pioneering the use of personalized cancer care to treat patients who have exhausted their standardized cancer treatment options.

Our experience in the integrative cancer field is unmatched, and we understand that breast cancer is a disease of genetic mutations, biomarkers, and molecular profiles.

Many of our patients leave our care wishing they had found us earlier.

But don’t take our word for it, hear from some of our amazing breast cancer success stories.

Breast Cancer Success Stories

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

How Does Breast Cancer Start?

Women who have at least one relative who has had breast cancer are almost twice as likely to develop breast cancer, and gene mutations like BRCA 1 & 2 are identified and used by Envita to build your breast cancer treatment [1].

However, 85% of breast cancer cases are not the result of inherited genetic mutation [1].

This builds a complicated landscape when trying to identify and treat the genetic factors of your breast cancer; whether they are inherited, environmental, or both, it is immensely important to identify these factors when establishing the proper course of treatment for your individualized breast cancer condition.

Our proprietary genetic testing is, by design, more in-depth than most clinics have access to, and it can identify genetic mutations that are causing and facilitating your breast cancer’s growth and potential metastatic spread.

We use this information to help form your true medical blueprint to attack your unique breast cancer treatment targets while strengthening your immune system and your body.

Establishing your true medical blueprint is the first step towards taking a personalized approach to your breast cancer treatment and, especially for breast cancer, genetic factors are an important part of that blueprint.

Commonly Overlooked Key Factors That Feed Breast Cancer

Envita uses a comprehensive treatment strategy that focuses on addressing commonly overlooked key factors that feed the development and metastatic spread of breast cancer.

There are three important microenvironment factors that must be properly addressed, these include Circulating Tumor Cells (CTCs), Vascular Endothelial Growth Factors (VEGF), and Microsatellite Instability (MSI).

What we have found in our twenty years of breast cancer treatment development is that these crucial key factors are drivers in the growth and spread of cancer and are essential targets in the development of Envita’s treatment protocols.

Understanding Your Breast Cancer’s Microenvironment

Cancer Biomarker targets

CTCs carry the most recently mutated form of the cancer’s genetic markers and provide valuable real-time genetic information.

Circulating tumor cells can be taken easily from your blood and are far superior to traditional biopsies because CTCs represent the most current mutations of your cancer giving Envita the most recent genomic information specific to your cancer.

Envita utilizes CTCs to identify mutational rates, immunotherapy targets, and genomic biomarkers which are then used to track changes in the cancer and deploy the appropriate treatments based on these metrics.

A graphical image depicting tumor cells

Vascular Endothelial Growth Factors, or VEGFs, promote the formation of new blood vessels that help tumors grow, and cancerous cells spread.

Envita’s doctors utilize personalized treatment protocols that combine customized integrative medicines with antiangiogenic smart drug technology that can silence cancerous blood vessel growth. This process helps to potentially decelerate and prevent further metastasis.

Why Microsatellite Instability Matters

Microsatellite Instabilities (MSI) are theorized to be the outcome of mutations that occur during DNA replication. MSI can facilitate the continued mutation of the cancerous cells, resulting in constantly changing treatment targets that can complicate and derail treatments.

By tracking microsatellite instability, Envita’s doctors can develop treatments to address these changes and help keep our patients one step ahead of their ever-mutating disease.

Fixing broken DNA
Replicating broken DNA

Epigenetic Influences on Breast Cancer Mutation

Epigenetic influences are important factors that act on cell mutation and growth, important factors that are often missed in conventional breast cancer treatment.

The Epigenetic influences of most concern are oncogenes and tumor suppressor genes. These genes can have a major impact on the formation and spread of cancer.

Oncogenes are mutated proto-oncogenes that case uncontrolled growth of a cell leading to the formation of cancer. Tumor suppressor genes, on the other hand, are genes that slow down cell division and repair DNA mistakes by signaling cancerous cells to die-off.

When these genes are mutated, cells can begin to grow out of control leading to cancer.

To affect the spread of cancer on an epigenetic level, we must both “turn off” oncogenes and “turn on” tumor suppressor genes and Envita has developed unmatched experience in identifying and modulating these genes.

A graphical image depicting COVID-19's mortality rate by age

Using MiRNA gene silencing, Envita’s treatment protocols promote the downregulation of oncogenes and the upregulation of tumor suppressor genes, promoting apoptosis of the cancerous cells. In this way we may initiate the body's natural defense against cancerous cells and possibly halt the growth and spread of the disease.

Reactivating the Immune System

Activating the immune system to identify and fight cancer cells can reinvigorate your fight against even aggressive and resistant cancers.

After cancer treatment with chemotherapy and radiation, many patients are left with ravaged immune systems which make them prone to infections and even further cancer development. Remember that destroying cancer cells is also one of the major functions of your immune system!

A robust and healthy immune system can adapt to the evolving menace that cancer represents and is closer to being recognized as being an integral part of the fight against cancer rather than relying on increasingly more potent toxins and radiation.

A properly regulated immune system can actively respond to new cancer cell mutations as they emerge over time.

Immunotherapy has shown to be effective for some metastatic cancer patients who have not responded well to other forms of cancer treatment.

A graphical image depicting COVID-19's mortality rate by age

Envita’s immunotherapy and immunotherapy adjunctive options are designed to re-establish the immune system and fine-tune it to recognize and destroy tumor cells, revitalizing your fight against cancer!

Genetically Targeted Fractionated Chemotherapy for Breast Cancer

We developed Genetically Targeted Fractionated Chemotherapy (GTFC) to provide a more targeted form of care while reducing many of the major side-effects associated with traditional chemotherapy administration.

Envita Medical Centers doesn't make any guarantee of outcomes. Results are not typical and will vary from person to person and should not be expected.

Standardized chemotherapy protocols call for a maximum therapeutic dose when administering chemotherapy because absorption of the drugs into cancerous cells is poor.

At Envita Medical Center our goal is to get 100% cancer cell absorption. Through therapeutic methods, we increase the amount of chemo-medication being absorbed into cancerous cells, allowing us to provide a unique approach to chemotherapy.

We can significantly decrease the dose of chemotherapy while increasing the number of chemo-agents being used and the frequency of administration [2].

This leads to focused chemotherapy that hits more biomarkers while decreasing the negative side-effects on the patient’s body.

GTFC uses genetic information to find chemotherapies that are best suited to attack your cancer, this is in stark opposition to the NCCN guidelines that require doctors to use specified chemotherapies based on condition instead of personalized genetic information.

We then use alternative and holistic medicine and therapies to influence your cancer cells into absorbing the chemotherapy and assist your body and immune system in recovering.

Finally, we use our in-house custom pharmacy to build the medications designed to address our patients’ genetic mutations.

The GTFC method allows us to use targeted chemotherapies at an increased frequency while utilizing smaller doses [2]. This treatment method helps increase the effectiveness of chemotherapy while simultaneously reducing the negative side-effects [2].

GTFC has also proven to be successful at combating cancer that has become resistant to treatment and is used in combination with other ancillary treatments and methods including immunotherapy that may help treat resistant forms of cancer.

We are very experienced with treating multi-drug resistant cancers and have done extensive research into the mechanisms that cancer cells use to pump chemo out of its cells and other factors that create a resistant form of cancer.

We aim to disable these pumps, reducing the cancer’s ability to fight against treatment while treating the root causes of your breast cancer, providing the best possible chance for our patients.

Non-Invasive Surgical Options Featuring CIPI™: Low Dose Chemoembolization

In addition to GTFC, Envita has developed interventional radiology procedures that are designed to treat inoperable tumors that are fibrous and difficult to penetrate through traditional intravenous chemotherapy means.

CIPI™, or Chemo Immuno Precision Injections is a precision form of tumor chemoembolization that utilizes Envita’s advanced world-class testing and meticulous genetic targeting to directly impact large tumor sites where surgery is not a viable option.

This exciting new therapy could revolutionize the treatment of breast cancer by diligently targeting hard to reach sites of metastasis like bone, lung, and liver.

This video is for informational purposes only. Individual results will vary. Envita makes no guarantees. Consult with your doctor to see if CIPI™ is right for you. Not every patient is a candidate for Chemo Immunotherapy Percutaneous Injection. Some cancers may not have actionable biomarkers or molecular profiles. Do not alter your medical care based on any information provided in this video. Please, consult your doctor prior to changing or stopping any current medical treatment you are receiving.

CIPI™ has the potential to increase medication delivery and maximize bioavailability by utilizing direct injection of genetically personalized micro-dosed medications into the tumor.

This can result in increased tumor kill while potentially reducing the debilitating side-effects normally associated with aggressive chemotherapies.

Envita’s Chemo Immuno Precision Injections are a revolutionary new alternative option for patients suffering from advanced breast cancer prognoses where traditional IV chemotherapy would not be appropriate.

There is no stone left unturned when you come to Envita, we utilize the world’s most effective and research-based medical therapies to treat your breast cancer at its source.

When you come to Envita we will work to find the best possible combination of these treatments based on your unique condition and attack your breast cancer from all angles.

If you are looking for a better approach to breast cancer treatment for you or a loved one, please contact our Patient Care Coordinators at 866-830-4576.

They are trained professionals and will be happy to answer any questions you have.

May God bless you on your journey to healing!


References

[1] Cancer.org, B. U.S. Breast Cancer Statistics. 2018 12/20/18 [cited 2019 01/03]; Available from: https://www.breastcancer.org/symptoms/understand_bc/statistics.

[2] Smith, A.J., J. Oertle, and D. Prato, Genetically Targeted Fractionated Chemotherapy. Journal of Cancer Therapy, 2015. Vol.06No.02: p. 17.

To better understand our unique approach to cancer treatment: